Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 1
2000 1
2003 1
2004 1
2006 1
2007 1
2008 1
2013 1
2014 1
2015 6
2016 3
2017 6
2018 9
2019 8
2020 11
2021 15
2022 11
2023 11
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II): The Trans Tasman Radiation Oncology Group 13.01 Phase 2 Randomized Clinical Trial.
Siva S, Bressel M, Mai T, Le H, Vinod S, de Silva H, Macdonald S, Skala M, Hardcastle N, Rezo A, Pryor D, Gill S, Higgs B, Wagenfuehr K, Montgomery R, Awad R, Chesson B, Eade T, Wong W, Sasso G, De Abreu Lourenco R, Kron T, Ball D, Neeson P; Stereotactic Ablative Fractionated Radiotherapy Versus Radiosurgery for Oligometastatic Neoplasia to the Lung (SAFRON) II Study Investigators. Siva S, et al. Among authors: de abreu lourenco r. JAMA Oncol. 2021 Oct 1;7(10):1476-1485. doi: 10.1001/jamaoncol.2021.2939. JAMA Oncol. 2021. PMID: 34455431 Free PMC article. Clinical Trial.
TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II.
Siva S, Chesson B, Bressel M, Pryor D, Higgs B, Reynolds HM, Hardcastle N, Montgomery R, Vanneste B, Khoo V, Ruben J, Lau E, Hofman MS, De Abreu Lourenco R, Sridharan S, Brook NR, Martin J, Lawrentschuk N, Kron T, Foroudi F. Siva S, et al. Among authors: de abreu lourenco r. BMC Cancer. 2018 Oct 23;18(1):1030. doi: 10.1186/s12885-018-4916-2. BMC Cancer. 2018. PMID: 30352550 Free PMC article. Clinical Trial.
Whither private health insurance?
Hall J, Viney R, de Abreu Lourenco R. Hall J, et al. Among authors: de abreu lourenco r. Aust N Z J Public Health. 1997 Apr;21(2):119-20. doi: 10.1111/j.1467-842x.1997.tb01669.x. Aust N Z J Public Health. 1997. PMID: 9161064 Free article. No abstract available.
What Does Metastasis-Free Survival Actually Mean?
Sweeney CJ, De Abreu Lourenco R, Hamid AA, Buyse M. Sweeney CJ, et al. Among authors: de abreu lourenco r. J Clin Oncol. 2019 Jul 1;37(19):1679-1680. doi: 10.1200/JCO.18.02372. Epub 2019 May 3. J Clin Oncol. 2019. PMID: 31050909 No abstract available.
If we do not count it, it does not count: ethnicity in allogeneic haemopoietic stem cell transplant in Australia.
McErlean G, Bajel A, Bhattacharyya A, Brown N, De Abreu Lourenco R, Greenwood M, Kerridge I, Kim N, Kliman D, Maneze D, O'Brien T, Szer J, Twist I. McErlean G, et al. Among authors: de abreu lourenco r. Intern Med J. 2023 Dec;53(12):2155-2158. doi: 10.1111/imj.16232. Epub 2023 Oct 10. Intern Med J. 2023. PMID: 37814833 No abstract available.
[18F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial.
Koh ES, Gan HK, Senko C, Francis RJ, Ebert M, Lee ST, Lau E, Khasraw M, Nowak AK, Bailey DL, Moffat BA, Fitt G, Hicks RJ, Coffey R, Verhaak R, Walsh KM, Barnes EH, De Abreu Lourenco R, Rosenthal M, Adda L, Foroudi F, Lasocki A, Moore A, Thomas PA, Roach P, Back M, Leonard R, Scott AM. Koh ES, et al. Among authors: de abreu lourenco r. BMJ Open. 2023 Aug 4;13(8):e071327. doi: 10.1136/bmjopen-2022-071327. BMJ Open. 2023. PMID: 37541751 Free PMC article.
82 results